Literature DB >> 20428980

Aortic thrombosis resolved with enoxaparin in a patient treated with cisplatin-based regimen for small cell lung cancer.

Sang Ouk Chin1, Jae Jin Lee, Yeon Hee Hwang, Jae Joon Han, Chi Hoong Maeng, Sun Kyung Baek, Cheong Woong Choi.   

Abstract

We present a rare case of a thrombus at the aortic arch found 1 month after cisplatin-based chemotherapy in a 50-year-old patient with a diagnosis of small cell lung cancer; there were no symptoms related to the thrombus. This patient did not have any predisposing factors for the development of an aortic thrombus before the chemotherapy was initiated. After immediate treatment with low molecular weight heparin (enoxaparin), the thrombus improved without any additional complications. Thus, we suggest that a hypercoagulable status possibly created by both the malignancy and cisplatin-based chemotherapy may have played a significant role in the development of the aortic thrombus.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20428980     DOI: 10.1007/s12185-010-0571-3

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  14 in total

1.  Arterial occlusion in patients with peripheral vascular disease treated with platinum-based regimens for lung cancer.

Authors:  J Mathews; R Goel; W K Evans; F Shamji; D J Stewart
Journal:  Cancer Chemother Pharmacol       Date:  1997       Impact factor: 3.333

2.  Venous thromboembolic disease. Clinical practice guidelines in oncology.

Authors:  Lawrence D Wagman; Melissa F Baird; Charles L Bennett; Paula L Bockenstedt; Spero R Cataland; John Fanikos; Patrick F Fogarty; Samuel Z Goldhaber; Tejpal S Grover; William Haire; Hani Hassoun; Mohammad Jahanzeb; Lawrence L Leung; Michael L Linenberger; Michael M Millenson; Thomas L Ortel; Riad Salem; Judy L Smith; Michael B Streiff
Journal:  J Natl Compr Canc Netw       Date:  2006-10       Impact factor: 11.908

3.  Prospective evaluation of major vascular events in patients with nonsmall cell lung carcinoma treated with cisplatin and gemcitabine.

Authors:  Gianmauro Numico; Ornella Garrone; Vincenzo Dongiovanni; Nicola Silvestris; Ida Colantonio; Gianna Di Costanzo; Cristina Granetto; Marcella Occelli; Elena Fea; Abdelamid Heouaine; Milena Gasco; Marco Merlano
Journal:  Cancer       Date:  2005-03-01       Impact factor: 6.860

Review 4.  Thromboembolic events during chemotherapy for germ cell cancer: a cohort study and review of the literature.

Authors:  N I Weijl; M F Rutten; A H Zwinderman; H J Keizer; M A Nooy; F R Rosendaal; F J Cleton; S Osanto
Journal:  J Clin Oncol       Date:  2000-05       Impact factor: 44.544

5.  Recurrent peripheral arterial thrombosis induced by cisplatin and etoposide.

Authors:  Rita M Cool; Jon D Herrington; Lucas Wong
Journal:  Pharmacotherapy       Date:  2002-09       Impact factor: 4.705

6.  Hypomagnesemia, renal dysfunction, and Raynaud's phenomenon in patients treated with cisplatin, vinblastine, and bleomycin.

Authors:  N J Vogelzang; J L Torkelson; B J Kennedy
Journal:  Cancer       Date:  1985-12-15       Impact factor: 6.860

7.  Development and validation of a predictive model for chemotherapy-associated thrombosis.

Authors:  Alok A Khorana; Nicole M Kuderer; Eva Culakova; Gary H Lyman; Charles W Francis
Journal:  Blood       Date:  2008-01-23       Impact factor: 22.113

8.  Modulation of tissue factor on human monocytes by cisplatin and adriamycin.

Authors:  J Walsh; H R Wheeler; C L Geczy
Journal:  Br J Haematol       Date:  1992-08       Impact factor: 6.998

9.  Acute ventricular and aortic thrombosis post chemotherapy.

Authors:  J F Morlese; T Jeswani; I Beal; P Wylie; J Bell
Journal:  Br J Radiol       Date:  2007-04       Impact factor: 3.039

10.  Acute abdominal aortic thrombosis in cancer patients.

Authors:  S Poirée; L Monnier-Cholley; J-M Tubiana; L Arrivé
Journal:  Abdom Imaging       Date:  2004-03-18
View more
  3 in total

1.  In the nick of time: arterial thrombosis on starting combination chemotherapy in metastatic gastric adenocarcinoma.

Authors:  Ian S Boon; Cheng S Boon
Journal:  BMJ Case Rep       Date:  2016-02-25

2.  Acute Arterial Thrombosis during Postoperative Adjuvant Cisplatin-based Chemotherapy for Completely Resected Lung Adenocarcinoma.

Authors:  Chihiro Sato; Kenichi Okuda; Hiroyuki Tamiya; Kota Yamamoto; Katsuyuki Hoshina; Osamu Narumoto; Hirokazu Urushiyama; Satoshi Noguchi; Yosuke Amano; Kosuke Watanabe; Akihisa Mitani; Hidenori Kage; Goh Tanaka; Yasuhiro Yamauchi; Daiya Takai; Takahide Nagase
Journal:  Intern Med       Date:  2017-12-08       Impact factor: 1.271

3.  D-dimer can be a diagnostic marker for cisplatin-related aortic thrombosis: A case report.

Authors:  Yu Matsumoto; Yasushi Horimasu; Kakuhiro Yamaguchi; Shinjiro Sakamoto; Takeshi Masuda; Taku Nakashima; Shintaro Miyamoto; Hiroshi Iwamoto; Kazunori Fujitaka; Hironobu Hamada; Noboru Hattori
Journal:  Medicine (Baltimore)       Date:  2021-02-19       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.